期刊文献+

胃肠道间质瘤中Ki-67、VEGF的表达及其意义 被引量:4

Expression of Ki-67 and VEGF and their clinicopathological significance in gastrointestinal stromal tumors
下载PDF
导出
摘要 目的探讨Ki-67及肿瘤转移密切相关的血管内皮细胞生长因子(VEGF)与胃肠道间质瘤(gastrointestinal stromaltumors,GIST)生物学行为分级的关系。方法选取70例GIST蜡块构建组织芯片,采用免疫组化法联合检测Ki-67及VEGF,并结合病理形态学及生物学行为分级进行分析。结果①Ki-67阳性17例(阳性率24·3%),其中,极低度侵袭危险性(VLR)0/6例,低度侵袭(LR)危险性1/16例,中度侵袭危险性(IR)3/21例,高度侵袭危险性(HR)13/27例,HR组Ki-67表达与IR、LR及VLR组之间差异有显著性(χ2=13·61,P<0·01);生物学行为分级与Ki-67表达呈正相关(r=0·435,P<0·01)。②VEGF阳性45例(阳性率64·3%),其中,VLR组(0/6例)的阳性表达率低于HR(22/27例)、LR(10/16例)及IR组(13/21例)(χ2=8·34,P<0·01)。梭形细胞型、混合细胞型和上皮样细胞型GIST的VEGF阳性率分别为51·2%(21/41)、82·4%(14/17)及83·3%(10/12),上皮样细胞型和混合细胞型的VEGF表达较梭形细胞型差异有显著性(χ2=7·40,P<0·01);VEGF的表达不但与生物学行为分级呈正相关(r=0·332,P<0·05),而且与病理形态学分型呈正相关(r=0·263,P<0·05)。结论Ki-67和VEGF的表达与GIST生物学行为关系密切,可作为GIST生物学行为的潜在评价指标。 Purple To explore the relationship between the expression of Ki-67 and vascular endothelial growth factor (VEGF) and biological behavior of gastrointestinal stromal tumors(GIST). Methods Two tissue microarrays(TMAs) contained 10×10 tissue cores were constructed, including 70 cases of GIST. These tissue sections were studied immunohistochemically for the expression of Ki-67 and VEGF, and their relations with histopathology and biological behavior were analyzed statistically. Results ① Out of 70 cases, 17 cases were positive for Ki-67(24. 3% ) , of which the very low-risk, low-risk, intermediate risk and high-risk groups were O, 1, 3 and 13 cases, respectively. In the 17 cases of Ki-67-positive tumors, high-risk group expressed Ki-67 more frequently(48. 1% ) than very low-risk(O case) , low-risk(6.25% ) and intermediate risk one( 14, 3% ) ( X^2 = 13.61, P 〈0. 01 ). There was a significant correlation between the expression of Ki-67 and biological behavior( r = 0. 435, P 〈 0. 01 ). ② 45 cases exhibited VEGF expression(64. 3% ) , of which the very low-risk, low-risk, intermediate risk and high-risk groups were 0, 10, 13 and 22 cases, respectively. In the 45 cases of VEGF-positive tumors, low-risk, intermediate risk and high-risk group expressed VEGF more frequently (70. 0% ) than the very low-risk (0 case) ( X^2 = 8. 34 ,P 〈0. O1 ). Spindle cell variant expressed VEGF less frequently (51.2%) than mixed cell variant(82. 4% ) and epithelioid cell variant( 83.3% ) (X^2 = 7.40,P 〈0. O1 ). There were not only significant relations between the expression of VEGF and the biological behavior( r = 0. 332, P 〈 0. 05 ) , but also between the expression of VEGF and pathological variants ( r = 0. 263, P 〈 0. 05 ). Conclusions Ki-67 and VEGF are closely related with the biological behavior of GIST, and they might be potential markers for evaluation of GIST behavior.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2006年第4期433-436,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 胃肠道间质瘤 血管内皮细胞生成因子 KI-67 gastrointestinal stromal tumors vascular endothelial growth factor Ki-67
  • 相关文献

参考文献11

  • 1杨其昌,季晓华,沈屹,韩枋,张晓娟,刘宏斌.74例胃肠道间质瘤临床病理与生物学行为评价[J].中华病理学杂志,2005,34(1):6-10. 被引量:68
  • 2Zsolt O,Tamas T,Zoltan S.Gastrointestinal stromal tumors:A clinicopathologic and immunohistochemical study of 136 cases[J].Pathol Oncol Res,2005,11(1):11-21.
  • 3侯英勇,王坚,朱雄增,杜祥,孙孟红,郑爱华.胃肠道间质瘤76例的临床病理及免疫组织化学特征[J].中华病理学杂志,2002,31(1):20-25. 被引量:231
  • 4Leah S,Douglas L,Carlos A,et al.Gastrointestinal stromal tumors[J].Cancer Control,2001,8(3):252-261.
  • 5Kononen J,Bubendorf L,Kallionieni A,et al.Tissue microarrays for high-throughput molecular profiling of tumor specimens[J].Nature Med,1998,4(7):844-847.
  • 6王占东,王小玲,吴国祥,杨会钗,王永军,陈砚凝.胃肠道间质瘤临床病理及免疫组织化学特征[J].临床与实验病理学杂志,2004,20(6):662-665. 被引量:12
  • 7Wang X J,Mori I,Tang W H,et al.Helpful parameter for malignant potential of gastrointestinal stromal tumors(GIST)[J].Jpn J Clin Oncol,2002,32(9):347-351.
  • 8Han H,Silverman J F,Santucci T S,et al.Vascular endothelial growth factor expression in stage Ⅰ non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis[J].Annals Surg Oncol,2001,8:72-79.
  • 9Fletch C D,Berman J J,Corless C,et al.Diagnosis of gastrointestinal stromal tumors:A consensus approach[J].Hum Pathol,2002,33(5):459-465.
  • 10RosaiJ 著 回允中 主译.阿克曼外科病理学[M](第8版)[M].沈阳:辽宁教育出版社,1999.2064.

二级参考文献38

  • 1Fletcher CD, Berman J J, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: A consensus approach. Hum Pathol,2002,33:459-465.
  • 2Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and M1B-1 grade. Hum Patho1,2002,33:669-676.
  • 3Miettinen M, E1-Rifai W, Sobin LH, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum Pathol,2002, 33:478-483.
  • 4Wang X, Mori J, Tang W, et al. Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST). Jpn J Clin Oncol, 2002,32 : 347-351.
  • 5Rudolph P, Chiaravalli AM, Pauser U, et al. Gastrointestinal mesenchymal tumors- immunophenotypic classification and survival analysis. Virchows Arch,2002,441 : 238-248.
  • 6Ignjatovic M. Gastrointestinal stromal tumors. Vojnosanit Pregl,2002,59 : 183-202.
  • 7Rosai J. Ackerman surgical pathology.8th ed. New York: Mosby-Book Inc,1996. 645-693.
  • 8Hirota S,Isozaki K,Moriyama Y, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science, 1998,279:577-580.
  • 9Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth muscle (stromal) tumors: dependence on anatomic site. Am J Clin Pathol, 1995,154 : 53-60.
  • 10Lewin KJ, Ridden RH, Weinstein WM, et al. Gastrointestinal pathology and its clinical implications. New York: lgaku-Shoin,1992. 284-341.

共引文献317

同被引文献19

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部